ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 194

$455K Total Retail Price of All Prescriptions

Rank: 58 out of 194

770 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $36 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 974 899 1 1
METOPROLOL SUCCINATE 900 743 2 4
AMLODIPINE BESYLATE 847 789 3 2
LOSARTAN POTASSIUM 636 554 4 3
ATENOLOL 559 492 5 7
LOSARTAN-HYDROCHLOROTHIAZIDE 534 461 6 5
ENALAPRIL MALEATE 376 324 7 6
VERAPAMIL ER 323 298 8 34
CLOPIDOGREL 319 282 9 16
PLAVIX 267 230 10 18
ISOSORBIDE MONONITRATE ER 228 204 11 12
FUROSEMIDE 223 216 12 14
DIGOXIN 221 203 13 26
METFORMIN HCL 216 199 14 9
LISINOPRIL 198 172 15 11
DOXAZOSIN MESYLATE 191 176 16 19
WARFARIN SODIUM 184 149 17 28
DIOVAN 184 165 17 32
HYDROCHLOROTHIAZIDE 159 134 19 13
CARVEDILOL 150 143 20 8
ATORVASTATIN CALCIUM 149 128 21 10
OMEPRAZOLE 147 125 22 23
PROPRANOLOL HCL 140 132 23 92
CRESTOR 134 111 24 27
SYNTHROID 133 123 25 17
IRBESARTAN 125 110 26 31
PRAVASTATIN SODIUM 118 77 27 25
FENOFIBRATE 117 92 28 36
PANTOPRAZOLE SODIUM 111 104 29 44
DIOVAN HCT 109 84 30 35
ATENOLOL-CHLORTHALIDONE 108 86 31 70
RANITIDINE HCL 106 94 32 22
LEVOTHYROXINE SODIUM 93 83 33 20
GABAPENTIN 92 90 34 21
CILOSTAZOL 90 86 35 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 63 36 40
AMLODIPINE BESYLATE-BENAZEPRIL 80 56 37 30
AVAPRO 79 67 38 41
GLIMEPIRIDE 72 72 39 29
POTASSIUM CHLORIDE 72 36 39 117
COUMADIN 68 49 41 38
CLONIDINE HCL 66 56 42 45
ASPIRIN EC 64 64 43 24
ZOLPIDEM TARTRATE 64 59 43 42
NIFEDIPINE ER 60 46 45 47
GEMFIBROZIL 57 53 46 63
AVALIDE 56 47 47 99
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 51 47 49
IRBESARTAN-HYDROCHLOROTHIAZIDE 54 54 49 65
SPIRONOLACTONE 54 38 49 37
METOPROLOL TARTRATE 53 53 51 15
LABETALOL HCL 50 47 52 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.